Search Results - "Sang-ho Jo"

Refine Results
  1. 1

    Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease by Cho, Kyoung Im, Sakuma, Ichiro, Sohn, Il Suk, Jo, Sang-Ho, Koh, Kwang Kon

    Published in Atherosclerosis (01-10-2018)
    “…Although calcific aortic stenosis is a very common disease with major adverse cardiovascular events and healthcare costs, there are no effective medical…”
    Get full text
    Journal Article
  2. 2
  3. 3

    New Trends in Dyslipidemia Treatment by Jang, Albert Youngwoo, Lim, Soo, Jo, Sang-Ho, Han, Seung Hwan, Koh, Kwang Kon

    Published in Circulation Journal (25-05-2021)
    “…Dyslipidemia is one of the most important risk factors for cardiovascular (CV) disease. Statin therapy has dramatically improved CV outcomes and is the…”
    Get full text
    Journal Article
  4. 4

    Omega-3 fatty acids and atrial fibrillation by Huh, Ji Hye, Jo, Sang-Ho

    Published in The Korean journal of internal medicine (01-05-2023)
    “…Although some clinical trials have demonstrated reduced incidence of cardiovascular disease with the use of omega-3 fatty acids, others have found an increased…”
    Get full text
    Journal Article
  5. 5

    Triglyceride-Rich Lipoproteins and Remnant Cholesterol in Cardiovascular Disease by Heo, Ji Hye, Jo, Sang-Ho

    Published in Journal of Korean medical science (2023)
    “…Despite the well-established benefits of statin treatments in lowering low-density lipoprotein cholesterol (LDL-C), a significant residual risk for…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Nighttime administration of antihypertensive medication: a review of chronotherapy in hypertension by Kim, Hyun-Jin, Jo, Sang-Ho

    Published in The Korean journal of internal medicine (01-03-2024)
    “…Hypertension remains a global health concern because of suboptimal blood pressure control despite advancements in antihypertensive treatments. Chronotherapy,…”
    Get full text
    Journal Article
  8. 8

    Percutaneous coronary intervention versus medical therapy in stable angina: a matched cohort study by Jo, Sang-Ho, Kim, Hoseob, Kim, Hyun-Jin, Lee, Min-Ho, Seo, Won-Woo, Kim, Mina, Kim, Hack-Lyoung

    Published in Heart (British Cardiac Society) (01-05-2024)
    “…It is uncertain whether percutaneous coronary intervention (PCI) in addition to optimal medical therapy (OMT) can reduce adverse clinical events in the long…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Coronary Plaque Characteristics and Cut-Off Stenosis for Developing Spasm in Patients with Vasospastic Angina by Jo, Sang-Ho, Sim, Ju Ho, Baek, Sang Hong

    Published in Scientific reports (31-03-2020)
    “…Coronary plaque distribution, frequency and cut-off value of percent stenosis for developing vasospasm are uncertain in patients with vasospastic angina (VA)…”
    Get full text
    Journal Article
  11. 11

    Nighttime administration of antihypertensive medication: a review of chronotherapy in hypertension by Hyun-jin Kim, Sang-ho Jo

    Published in The Korean journal of internal medicine (31-03-2024)
    “…Hypertension remains a global health concern because of suboptimal blood pressure control despite advancements in antihypertensive treatments. Chronotherapy,…”
    Get full text
    Journal Article
  12. 12

    Metabolic syndrome epidemic among Korean adults: Korean survey of Cardiometabolic Syndrome (2018) by Huh, Ji Hye, Kang, Dae Ryong, Jang, Ji-Yun, Shin, Jeong-Hun, Kim, Jang Young, Choi, Seonghoon, Cho, Eun Joo, Park, Jin-Sun, Sohn, Il Suk, Jo, Sang-Ho, Sung, Ki-Chul, Koh, Kwang Kon

    Published in Atherosclerosis (01-10-2018)
    “…Little information exists on the prevalence of metabolic syndrome (MetS) in Korea since 2007. We aimed to provide up-to-date estimates of the prevalence of…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Omega-3 fatty acids and atrial fibrillation by Ji Hye Huh, Sang-ho Jo

    Published in The Korean journal of internal medicine (01-05-2023)
    “…Although some clinical trials have demonstrated reduced incidence of cardiovascular disease with the use of omega-3 fatty acids, others have found an increased…”
    Get full text
    Journal Article
  15. 15

    Clinical impact of statin therapy on vasospastic angina: data from a Korea nation-wide cohort study by Seo, Won-Woo, Jo, Sang-Ho, Kim, Sung Eun, Han, Seung Hwan, Lee, Kwan Yong, Her, Sung Ho, Lee, Min-Ho, Cho, Sung Seek, Baek, Sang Hong

    Published in Heart and vessels (01-08-2020)
    “…The effect of statin therapy on reducing adverse cardiovascular events in vasospastic angina (VSA) has been inconsistent. Therefore, we investigated the…”
    Get full text
    Journal Article
  16. 16

    Admission serum potassium levels and prognosis of vasospastic angina by Seo, Won-Woo, Jo, Sang-Ho, Kim, Sung Eun, Kim, Hyun-Jin, Han, Seung Hwan, Lee, Kwan Yong, Her, Sung Ho, Lee, Min-Ho, Cho, Seong-Sik, Kim, Hack-Lyoung, Baek, Sang Hong

    Published in Scientific reports (11-03-2021)
    “…Hypokalemia is a common electrolyte disturbance and is related to poor prognosis in patients with cardiovascular disease. However, the role of hypokalemia in…”
    Get full text
    Journal Article
  17. 17

    Current Evidence on Long-Term Prognostic Factors in Vasospastic Angina by Kim, Hack-Lyoung, Jo, Sang-Ho

    Published in Journal of clinical medicine (21-09-2021)
    “…Vasospastic angina (VSA) is characterized by a reversible spasm of the coronary arteries and is more prevalent in Asians. Vasodilators, such as calcium channel…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up by Jeong, Han Saem, Lim, Hong‐Seok, Park, Hun-Jun, Lee, Wang-Soo, Choi, Jin-Oh, Lee, Hui Seung, Jo, Sang-Ho, Hong, Soon Jun

    Published in Scientific reports (19-01-2021)
    “…Although both angiotensin receptor blockers (ARBs) and dihydropyridine calcium channel blockers (CCBs) are all suitable for the initiation of antihypertensive…”
    Get full text
    Journal Article
  20. 20

    Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Heart Failure With Chronic Kidney Disease ― Propensity Score Matching Analysis by Kim, Hyun-Jin, Lee, Min-Ho, Jo, Sang-Ho, Seo, Won-Woo, Kim, Sung Eun, Kim, Kyung-Jin, Choi, Jin-Oh, Ahn, Hyo-Suk, Choi, Dong-Ju, Ryu, Kyu-Hyung

    Published in Circulation Journal (25-12-2019)
    “…Background:Whether angiotensin-converting enzyme inhibitor (ACEI) or angiotensin-receptor blocker (ARB) exert beneficial effects in patients with concomitant…”
    Get full text
    Journal Article